Expression of urokinase type plasminogen activator (u-PA) and U-PA inhibitor (PAI-1) in lung cancers: Clinical significance

被引：0
|
作者：
Brambilla, E [1 ]
Robert, C [1 ]
Bolon, I [1 ]
Decaussin, M [1 ]
机构：
[1] CHU Grenoble, Lung Canc Res Grp, Pathol Lab CJF 97 01, F-38043 Grenoble, France
来源：
LABORATORY INVESTIGATION | 1999年 / 79卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1066
引用
收藏
页码：181A / 181A
页数：1
相关论文
共 50 条
  • [21] Thrombin stimulation of platelets induces plasminogen activation mediated by urokinase type plasminogen activator (u-PA)
    Lenich, C
    Liu, JN
    Gurewich, V
    THROMBOSIS AND HAEMOSTASIS, 1997, : P3073 - P3073
  • [22] UROKINASE (U-PA) AND TISSUE PLASMINOGEN-ACTIVATOR (T-PA) ARE RELEASED TOGETHER WITH A PLASMINOGEN-ACTIVATOR INHIBITOR (PAI) FROM ENDOMETRIAL TISSUE IN CULTURE
    CASSLEN, B
    NILSSON, IM
    ASTEDT, B
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 269 - 269
  • [23] THE UROKINASE PLASMINOGEN-ACTIVATOR (U-PA) AND ITS INHIBITOR (PAI-1) IN EMBRYO-FETAL BONE-FORMATION IN THE HUMAN - AN IMMUNOHISTOCHEMICAL STUDY
    HACKEL, C
    RADIG, K
    ROSE, I
    ROESSNER, A
    ANATOMY AND EMBRYOLOGY, 1995, 192 (04): : 363 - 368
  • [24] The influence of surgery on plasminogen activators (t-PA, u-PA) and its inhibitor (PAI-1) in patients with colorectal adenocarcinoma
    Zekanowska, E
    Jawien, A
    Tojek, K
    Michalski, A
    Alski, B
    Kotschy, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS605 - PS605
  • [25] THE ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PAI-2) IN KERATINOCYTE PROLIFERATION
    HIBINO, T
    OONUMA, M
    TAKAHASHI, T
    HORII, I
    CLINICAL RESEARCH, 1992, 40 (02): : A514 - A514
  • [26] AVIAN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) LACKS THE PUTATIVE BINDING-SITE FOR PLASMINOGEN-ACTIVATOR INHIBITOR (PAI) AND IS RESISTANT TO INHIBITION BY HUMAN PAI-1 AND PAI-2
    TESTA, JE
    STEFANSSON, S
    SIOUSSAT, T
    QUIGLEY, JP
    FIBRINOLYSIS, 1995, 9 (02) : 93 - 99
  • [27] Prognostic significance of the urokinase type plasminogen activator (u-PA) system in node-negative breast cancer
    Eiichi Shiba
    Seung Jin Kim
    Tetsuya Taguchi
    Fumine Tsukamoto
    Shinzaburo Noguchi
    Breast Cancer, 1999, 6 (4) : 357 - 360
  • [28] DDAVP INDUCES SYSTEMIC RELEASE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA)
    LEVI, M
    TENCATE, JW
    DOOIJEWAARD, G
    STURK, A
    BROMMER, EJP
    AGNELLI, G
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 330 - 330
  • [29] Auto-induction of urokinase type plasminogen activator (u-PA) in endothelial cells and monocytes
    Li, C
    Jiang, Y
    Tang, W
    Gurewich, V
    Liu, JN
    THROMBOSIS AND HAEMOSTASIS, 1997, : P3070 - P3070
  • [30] THE ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND PALSMINOGEN ACTIVATOR INHIBITOR-2 (PAI-2) IN KERATINOCYTE PROLIFERATION
    HIBINO, T
    OONUMA, M
    TAKAHASHI, T
    HORII, I
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (04) : 633 - 633
12345